Table 2.
Factors associated with S. aureus skin and soft tissue infections in pemphigus patients and other skin infections.
| Pemphigus patients | Other skin infection | OR (95% CI) | p value | |
|---|---|---|---|---|
| MRSA | 49 (42.2) | 29 (46) | 2.3 (1.2–4.2) | 0.006 |
| MDR | 61 (52.5) | 35 (55.5) | 1.8 (1.03–3.3) | 0.036 |
| PVL gene | 25 (21.5) | 10 (15.8) | 1.1 (0.5–2.3) | 0.7 |
| Sex (male/female) | 63/53 | 28/35 | 0.6 (0.36–1.15) | 0.13 |
| Nosocomial infection | 22 (18.9) | 17 (26.9) | 2.28 (1.06–4.9) | 0.032 |
| Antibiotic usage | 94 (81.03) | 53 (84.1) | 3.28 (1.57–6.81) | 0.001 |
| Usage of vancomycin | 22 (18.9) | 20 (31.7) | 4.09 (1.7–9.6) | 0.001 |
| Usage of aminoglycosides | 42 (36.2) | 24 (38) | 3.39 (1.7–6.6) | <0.001 |
| Previous antibiotic usage | 17 (14.6) | 9 (14.2) | 2.61 (1.08–6.29) | 0.028 |
| Corticosteroids usage | 79 (68.1) | 35 (55.5) | 4.6 (2.5–8.7) | <0.001 |